Skip to main content

Therapeutics Startups

Updated October 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,723 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,723
Total Funding
$1.9B
Avg Funding
$75.6M
Global Reach
7
countries

Top Cities for Therapeutics

Aurora
Cambridge
Basel
Singapore
San Francisco
Toronto

Recently Funded Companies

Export
Aurora, United States

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

$40.0M raised
Jun 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

$40.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

Jun 2023

Founder Contacts

41,000+ verified contacts

Singapore, Singapore

Lion TCR is a clinical-stage biotechnology company.

$41.6M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

$8.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

$3.5M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Medicenna is a clinical stage, privately held, immuno-oncology company.

$4.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Lund, Sweden

Oncorena treatment for renal cancer

$14.0M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

$3.0M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

$200.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Newton, United States

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

$1.0M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

San Francisco, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

$10.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Oakland, United States

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

$62.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Amsterdam, The Netherlands

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

$45.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

$59.2M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Aldena Therapeutics is a private biotech startup that invented siRNA-based treatments for dermatological conditions.

$656K raised
Jun 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

$20.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Arlington, United States

Yutide Therapeutics is an animal health biotechnology company that develops therapeutics and antimicrobial peptides for companion animals.

$375K raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Chellaston, United Kingdom

Thalia Therapeutics is a drug reformulation company.

$3.6M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Austin, United States

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

$330.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Edmonton, Canada

48Hour Discovery is involved in peptide-based drug discovery services.

$837K raised
Jun 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.

$7.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.

$1.4M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

$805.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

$190.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Showing 401 to 425 of 1,723 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,723 therapeutics companies tracked in the VCBacked database.

Average Funding
$75.6M
Total Funding Tracked
$1.9B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
4 companies$228.0M
2.Cambridge
2 companies$43.5M
3.New York
2 companies$812.0M
4.Aurora
1 companies$40.0M
5.Basel
1 companiesUndisclosed

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,723 Therapeutics Startups (2026) — Recently Funded — Page 17 | VCBacked